ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

Solange Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.